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Abstract The consumption of green tea has been associated
with cardiovascular and metabolic diseases. There have
been some studies on the influence of green tea on the
mineral status of obese subjects, but they have not yielded
conclusive results. The aim of the present study is to exam-
ine the effects of green tea extract on the mineral, body
mass, lipid profile, glucose, and antioxidant status of obese
patients. A randomized, double-blind, placebo-controlled
study was conducted. Forty-six obese patients were random-
ly assigned to receive either 379 mg of green tea extract, or a
placebo, daily for 3 months. At baseline, and after 3 months
of treatment, the anthropometric parameters, blood pressure,
and total antioxidant status were assessed, as were the levels
of plasma lipids, glucose, calcium, magnesium, iron, zinc,
and copper. We found that 3 months of green tea extract
supplementation resulted in decreases in body mass index,
waist circumference, and levels of total cholesterol, low-
density cholesterol, and triglyceride. Increases in total anti-
oxidant level and in zinc concentration in serum were also
observed. Glucose and iron levels were lower in the green
tea extract group than in the control, although HDL-
cholesterol and magnesium were higher in the green tea
extract group than in the placebo group. At baseline, a
positive correlation was found between calcium and body
mass index, as was a negative correlation between copper
and triglycerides. After 3 months, a positive correlation
between iron and body mass index and between magnesium
and HDL-cholesterol, as well as a negative correlation be-
tween magnesium and glucose, were observed. The present
findings demonstrate that green tea influences the body's
mineral status. Moreover, the results of this study confirm
the beneficial effects of green tea extract supplementation on
body mass index, lipid profile, and total antioxidant status in
patients with obesity.
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Introduction
Overweight and obesity represent rapidly growing threats to
the health of populations in an increasing numbers of
countries worldwide. The adverse health consequences as-
sociated with obesity include cardiovascular disease, type 2
diabetes, hypertension, dyslipidemia, cancers, and respira-
tory problems. Increasing evidence shows that obesity is
associated with insulin resistance, with chronic low-grade
inflammatory responses, and with oxidative stress [1, 2].
Oxidative stress consists of unbalanced higher cellular
levels of reactive oxygen species (ROS), e.g., superoxide
and hydroxyl radicals and cellular antioxidant defense [3].
The generation of ROS is ubiquitous, since such species are
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generated during aerobic metabolism, i.e., during mitochon-
drial and glycated protein oxidations. Blood may be vulner-
able to oxidative stress induced by diabetes and may
become exposed to ROS continuously generated by the
auto-oxidation of hemoglobin and polyunsaturated fatty
acids (PUFAs) [4, 5]. Because of their high rate of oxygen
consumption, their high content of PUFAs, and their poor
enzymatic antioxidant defense, blood cells exhibit increased
vulnerability to diabetes-induced oxidative stress [4, 5].
Lipid peroxidation (LP) causes injury to cells and to intra-
cellular membranes and may lead to cell damage and sub-
sequently to cell death [6]. In order to scavenge ROS,
various enzymatic and nonenzymatic antioxidant defense
systems exist in the blood [7].
Moreover, many of the metabolic imbalances involved in
obesity (e.g., glycemic, lipidemic) give rise to organ dys-
function and accelerated aging processes [8]. Several studies
show obesity-related abnormalities in mineral status. The
association between overweight, obesity, Fe, calcium Ca,
and Zn deficiency has been observed in clinical and epide-
miological studies [9]. Several studies suggest that Ca may
play a role in the regulation of abdominal fat mass in obese
people [10].
Understanding these pathological processes is crucial for
better prevention and treatment of patients with obesity. The
possible use of so-called functional food in this group of
patients is particularly intriguing.
In recent years, researchers throughout the world have
been investigating the potential benefits of green tea (GT)
and i t s mo s t a bund an t c a t e c h i n , po l ypheno l
epigallocatechin-3-gallate (EGCG). The positive effects of
GT supplementation have been observed particularly in the
prevention and control of type 2 diabetes [11]. In recent
years, there have been a number of trials in humans showing
the favorable effects of GT supplementation on body weight
and body composition [12]. GT also has positive effects in
the prevention and treatment of cardiovascular diseases
[13]. Human studies suggest that GT may contribute to a
reduction in the risk of atherosclerosis and cancer, as well as
to the promotion of anti-hypertensive effects, body-weight
control, antibacterial effects, increases in bone-mineral den-
sity, anti-fibrotic properties, and neuroprotective power [14].
There is growing evidence showing the possibility of using
GT in the prevention and treatment of obesity and coexisting
diseases [11, 15].
Several reports have focused on the interactions of
polyphenols with metal ions, e.g., Zn and Fe, and have
suggested their possible influence on mineral distribu-
tion in the body [16, 17]. There are few studies on the
effects of GT on mineral status. The small number of
studies evaluating green tea extract's (GTE) influence on
mineral status in obese patients have shown inconclu-
sive results.
The aim of our study was to estimate the influence of a 3-
month oral supplementation of GTE on serum concentra-
tions of minerals, on body mass, on total antioxidant status,




Informed consent was obtained from all subjects, and the
study was approved by the Research Ethics Committee of
Poznan University of Medical Sciences (approval number
38/11). The research conformed to all the ethical require-
ments of the Helsinki declaration.
Among 145 registered patients with obesity screened at
our outpatient clinic, a total of 46 (23 men, 23 women) were
enrolled. The inclusion criteria were: age 30–60 years, body
mass index (BMI)≥30 kg/m2, stable body weight (less than
3 kg of self-reported change during the previous 3 months).
The exclusion criteria were hypertension; diabetes; impaired
glucose tolerance; a current need for pharmacological treat-
ment; a history of coronary artery disease, stroke (including
transient ischemic attack), congestive heart failure, or ma-
lignancy; a history of use of any dietary supplements within
3 months prior the study; abnormal liver, kidney or thyroid
gland function; clinically significant inflammatory process-
es within the respiratory, digestive, or genitourinary tract, or
in the oral cavity, pharynx, or paranasal sinuses; a history of
infection in the month prior to the study; and any other
condition that in the opinion of the investigator would make
participation not in the best interest of the subject, or could
prevent, limit, or confound the protocol-specified efficacy
assessments.
Study Design
A prospective, randomized, double-blind design was ap-
plied. Randomization was performed by an independent
statistician. Both patients and investigators were blinded to
randomization.
All patients were randomized to receive green tea extract
(Olimp Labs, Poland) at one capsule per day, or a placebo,
with the morning meal for 3 months. One capsule contains
379 mg green tea extract and 208 mg of EGCG. The
quantity of minerals in one capsule of the supplement is
shown in Table 1. On the basis of the level of minerals in the
supplement, it can be concluded that the daily intake of
minerals from green tea extract was negligible. The placebo
consisted of pure microcrystalline cellulose. All subjects
were instructed to maintain an isocaloric diet and to contin-
ue their previous eating habits during the study. Subjects did
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not change their diet or physical activity during the study.
The exercise and daily eating regimes were comparable in
both groups.
At the baseline, and again after 3 months of treatment, the
anthropometric parameters, blood pressure measurement,
and other laboratory tests were performed on both groups.
Anthropometric and Blood Pressure Measurements
Anthropometric measurements were conducted with
patients wearing light clothing and no shoes. Weight was
measured to the nearest 0.1 kg, and height to the nearest
0.5 cm. The BMI was calculated as weight divided by height
squared (kilogram per square meter). Obesity was defined as
BMI≥30 kg/m2.
Resting seated blood pressure was measured three times,
and an average value was calculated according to the guide-
lines of the European Society of Hypertension. Regular or
large adult cuffs were used, depending on the patient's arm
circumference.
Biochemical Measurements
All participants had blood collected from a forearm vein in
serum-separated tubes (without using an anticoagulant). The
coagulated blood was left to clot at room temperature for
30 min, and then centrifuged for 15 min at 2,000 r.p.m. at 4 °
C. The supernatant fluid was then separated. Blood samples
were collected after an overnight fast and after 30 min in the
supine position. Serum samples were stored at −20 °C for no
longer than 2–3 days.
The iron, copper, zinc, calcium, and magnesium content
in the serum was determined by flame atomic absorption
spectrometry (AAS-3 spectrometer, Carl Zeiss, Germany
with deuterium background correction). In order to obtain
the concentrations of the serum bioelements, the samples
were diluted (v/v 1:1) as follows: for Fe, Zn, and Cu anal-
yses, 0.01 % Triton X-100 (Merck) was used, while for the
Mg and Ca analysis, aqueous solutions consisting of 0.01 %
Triton X-100 (Merck) and 0.05 % lanthanum chloride
(Merck) were used. The content of Fe, Cu, Zn, Ca, and
Mg in serum and urine samples was determined at the
following wavelengths: 248.3 nm (Fe), 324.8 nm (Cu),
213.9 nm (Zn), 422.7 nm (Ca), and 285.2 nm (Mg). The
accuracy of the method was verified by certified reference
material (HUM ASY CONTROL 2 and URN ASY CON-
TROL 2, Randox) and reached 95 %, 99 %, 94 %, 99 %,
and 102 % for Ca, Mg, Fe, Zn, and Cu, respectively.
Plasma total cholesterol (TC), high-density lipopro-
tein (HDL), triglycerides (TG), and fasting glucose were
measured using commercial kits. Serum levels of lipids
were assayed in the central laboratory of Poznan Uni-
versity Hospital. Low-density lipoprotein cholesterol
(LDL-C) was calculated using Friedewald's formula.
Levels of blood glucose were determined by the routine
enzymatic method.
The accuracy and precision of the techniques used to
assay the lipids and glucose were validated. Reproducibility
was checked with control human serum. Accuracy was
assessed through the recovery value and it ranges between
95 % and 109 % and the variability coefficient, as an
indicator of method precision, did not exceed 10 %.
Total antioxidant status (TAS) was established with a
Randox kit (Randox laboratories, Crumlin, UK). This method
is based on ABTS (2.2 azinobis 3-ethybenzthiazolinesulfate)
incubation with metmyoglobin, and H2O2 with eventual
ABTS-derived radical formation. This radical has a stable
blue-green color at a wave length of 600 nm. Antioxidants
present in the sample weaken the color intensity in proportion
to their concentration. Initial absorbance was recorded, and
then after 3 min, was recorded again for each sample using a
Specord M-40 Carl-Zeiss Jena spectrophotometer (SPE-
CORD M40, Carl Zeiss Jena, Germany).
Statistical Analysis
Detailed statistical analysis was performed using Statistica
for Windows. The normality of the variables' distribution
was verified using Shapiro–Wilk's test of normality. A log-
arithmic transformation was used to normalize non-
normally distributed dependent variables. Mean values,
standard deviation, and median were calculated. Baseline
characteristics of biochemical and demographic variables
and blood pressure values were compared for the GTE and
placebo groups, using the standard t test for two groups.
Paired t tests were utilized to examine within-group differ-
ences at baseline and after 3 months. The level of statistical
significance was set to p<0.05.
Results
Forty-six out of 145 obese patients with hypertension
screened at our outpatient clinic fulfilled the inclusion and
exclusion criteria and were allocated equally into the GTE
and placebo groups.
Table 1 The amount of minerals in green tea extract
Ca Mg Fe Zn Cu
μg/g
61.12±8.28 1098.04±148.3 5.67±0.34 1.81±0.32 0.51±0.17
μg/one capsule
23.22±3.42 416.24±56.3 2.15±0.06 0.68±0.11 0.19±0.03
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The baseline characteristics of both groups are shown in
Table 2, partly in Table 3, and in Figs. 1 and 2. There were
no statistically significant differences (p>0.05) between the
two groups prior to the study.
Between-Group Comparison after 3-Month Treatment
We found markedly lower levels of TC (p<0.01), TG
(p<0.01), and LDL (p00.02) in the GTE group than in the
control group after GTE treatment (Table 3, Figs. 1 and 2).
Compared to the placebo group, BMI and waist circumfer-
ence values significant decreased (respectively, p00.03 and
p00.04) in GTE group after 3-month treatment (Table 3).
TAS and Zn levels were markedly higher (respectively,
p<0.01 and p00.03) in the GTE group than in placebo
group (Tables 3 and 4). No differences were found in the
levels of glucose, HDL, blood pressure, or in the rest of the
measured minerals between groups after treatment.
Within-Group Comparison after 3-Month Treatment
Compared to the baseline measurements, 3-month treatment
with GTE resulted in a change in the measured parameters
only in the GTE group. GTE treatment caused significant
reduction in TC and TG (respectively, p00.034 and
p00.042) (Figs. 1 and 2), LDL (p00.035), glucose
(p00.043), Fe (p00.048), and significant increase in HDL
(p00.044), TAS (p00.036), Zn (p00.037), and Mg
(p00.047)—see Tables 3 and 4.
Correlation
A significant positive correlation between Ca and BMI (p0
0.042), and a negative correlation between Cu and TG (p0
0.038) were observed before treatment. After the 3-month
supplementation, significant positive correlations be-
tween Fe and BMI (p00.023), and between Mg and
HDL cholesterol (p00.023) were found, as was a sig-
nificant negative correlation between Mg and glucose
(p00.002) (Table 5).
Discussion
The significant influence demonstrated in our study of a
3-month GTE supplementation on mineral levels in obese
patients is a new finding. Moreover, the favorable effect of
GTE supplementation on body mass, lipid profile, glucose,
and antioxidant status was also demonstrated.
The potential of green tea as a natural agent of weight
loss has been investigated in some other studies similar to
our own [18, 19]. Some authors suggest that the polyphe-
nolic components of green tea have an anti-obesogenic
effect on fat homeostasis, by increasing thermogenesis, re-
ducing fat absorption, and introducing modifications in ap-
petite [20, 21]. The results obtained (significant differences
in BMI between the GTE group and the placebo group, and
the slight reduction in BMI in the group with GTE) support
the possible role of green tea in weight loss.
A number of experimental studies have been conducted
to examine the effects of GT on carbohydrate metabolism
and lipid profile [15, 19, 22]. Wu et al. [15] demonstrated
that during 12-week GT supplementation, insulin sensitivity
in Sprague–Dawley rats increased. They concluded that the
most active component in GT is polyphenol.
Abnormalities of lipid metabolism are one of the major
risk factors for the development of cardiovascular disease,
very often associated with obesity. The outcomes of our
study show that a 3-month supplementation exerts a positive
effect on lipid profile in patients with obesity. Decreases in
TC, LDL, and TG concentration were observed, along with
increases in HDL concentration (within the study group).
The positive effect of GT in human studies has also been
observed by others [19, 23]. The results could be partly
caused by the decreased absorption of cholesterol and glu-
cose from the diet in the presence of the polyphenols from
GTE in the small intestine, especially if the supplement is
taken by subjects during meals [24]. GT catechins influence
micellar solubility, luminal lipid hydrolysis, and intestinal
lipid absorption, and they may interfere with the emulsifi-
cation, hydrolysis, and micellar solubilization of lipids, sug-
gesting that the cholesterol-lowering effect of catechins
Table 2 Baseline characteristic of both groups
Gender (male/female) GTE group (n023) Placebo (n023) p
11/12 12/11 NS
Age (years) 48.56±8.81 52.26±7.71 NS
Time since diagnosis of obesity (years) 9.70±2.30 8.35±2.85 NS
BMI (kg/m2) 32.07±2.41 33.45±2.65 NS
Waist circumference (cm) 101.78±6.42 104.98±6.35 NS
Comparison of GTE and placebo group with unpaired t test
Data are mean ± SD; mean the arithmetic mean; SD standard deviation, n number of subjects, GTE green tea extract, BMI body mass index, NS not
significant, p level of significance
318 Suliburska et al.
may, at least in part, be mediated by their influence on
intestinal lipid absorption [25, 26].
We found a beneficial influence of GTE on oxidative
stress. An increase in TAS levels in the serum was observed
after supplementation. Tea catechins eliminate reactive ox-
ygen and nitric radicals, and also act as chelators of metal
ions active in the system redox. Both radicals and active
metal ions are highly toxic because of their destructive effect
on lipids, proteins, and nucleic acid. They also interact to
indirectly influence the inhibition of pro-oxidative enzymes,
such as nitric oxide synthetase, lipooxygenase, cyclooxyge-
nase, and xanthine oxidase [27, 28].
A literature review shows that the effect of GTE on
mineral status has not been widely studied, and the present
study shows novel results on this topic.
In our study, a decreased Fe level in the serum of obese
patients supplemented with GTE was observed. This lower
level of Fe in serum after treatment may be caused by the
low availability of this mineral, as suggested by Zeyuan et
al. [29]. In their experiment on rats, they found that GT and
its water extract inhibited the absorption of Ca, Fe, and Zn,
and promoted absorption of Cu. In particular, the polyphe-
nols contained in GT chelate Fe and might cause it to be less
well absorbed, leading to a lower concentration in the body
[17, 30]. On the basis of our results, it can be concluded that
GT supplementation may reduce the level of Fe in the blood
of obese people, and thereby increase the deficit of this
mineral in the body.
Moreover, in our study, an association was found be-
tween the concentration of Fe in serum and the BMI of
patients after the 3-month treatment. Some authors have
suggested that the alternation of Fe biomarkers in the obese
population could be a result of obesity-related inflammation
or of related comorbidities. Obesity has been reported to
Table 3 Within-group anthropometric, blood pressure, and biochemical data at baseline and after 3 months of treatment






















DBP (mmHg) 85.10±12.47 84.21±3.32 NS 84.06±12.26 84.50±3.86 NS
LDL (mmol/L) 3.44±1.03 3.80±1.19 NS 3.02±0.96* 3.71±1.12 0.02
HDL (mmol/L) 1.12±0.24 1.09±0.25 NS 1.28±0.26* 1.15±0.21 NS
Glucose (mmol/L) 5.64±0.44 5.67±0.44 NS 5.48±0.31* 5.59±0.43 NS
TAS (mmol/L) 1.91±0.23 1.90±0.15 NS 2.09±0.28* 1.91±0.13 <0.01
Data are mean ± SD; the arithmetic mean; SD standard deviation, n number of subjects; *p<0.05 from baseline to the end of treatment with paired t
test
GTE green tea extract, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, LDL LDL cholesterol concentration, HDL








 significantly differences (p<0.05) within group from baseline to the end of treatment  
a,b
 significantly differences (p<0.01) between GTE and placebo groups 
Fig. 1 Concentration of total cholesterol (millimole per liter) in serum
at baseline and after 3 months of treatment. *, ** Significant differences
(p<0.05) within group from baseline to the end of treatment. a,b









 significantly differences (p<0.05) within group from baseline to the end of treatment  
a,b
 significantly differences (p<0.01) between GTE and placebo groups 
Fig. 2 Concentration of triglycerides (millimole per liter) in serum at
baseline and after 3 months of treatment. *, ** Significant differences
(p<0.05) within group from baseline to the end of treatment. a,b
Significant differences (p<0.01) between GTE and placebo groups
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induce an inflammatory state, and some studies have sug-
gested that inflammation contributes to high serum Fe levels
in obese subjects [31]. In this study, the reduction in BMI
index was associated with a decrease in inflammation bio-
markers (unpublished data) and in the serum Fe level.
As with other authors, we found that GT treatment re-
duced Fe status and improved Zn and Mg status in patients
and experimental animals [16, 17]. The increased Zn level in
the serum may be associated with improved antioxidant
status subsequent to GT treatment, as concluded by Ham-
daoui et al. [16].
We have also observed an association between glucose
and Mg, which confirms the results of other studies [32, 33].
In this study, we observed following supplementation that
there were increased concentrations of Mg associated with
decreased levels of glucose in the serum of the GTE group.
It may be suggested that higher levels of Mg in the body led
to a reduction in plasma glucose and stabilized the glucose
level during treatment. Soltani et al. [34] concluded that Mg
could improve the structure of the pancreas (especially in
diabetic individuals) and may prevent morphological
changes of blood vessels. In this study, the improvement
in Mg status after GTE supplementation was associated with
higher levels of HDL cholesterol in the serum of patients. A
positive correlation between Mg in serum and HDL has also
been observed by other authors [35]. The results obtained in
experimental and clinical studies suggest the higher Mg
levels in the body are associated with a beneficial effect on
lipid profile [36, 37].
In this study, we did not find any change in Ca levels of
serum during GTE treatment. Other studies have shown that
supplementation with GT polyphenols results in an increase
in bone-mineral density and a decrease in urinary calcium
levels [38, 39]. In this study, we did not evaluate the con-
centration of this mineral in other tissues, such as bones. The
lack of effect of GTE supplementation on serum Ca levels in
patients in this study may be due to factors of homeostasis in
the bodies of the subjects during treatment.
Moreover, at the baseline of the study, we observed a
negative correlation between Cu and TG levels in serum. A
similar association between Cu and TG in the serum of
obese patients with hypertension was found in our previous
study [40], and has also been observed by others [41]. These
results confirm the association between Cu status and lipid
profile in the body.
It is also worth noting that prior to the treatment, the
patients' BMI was positively correlated with the concentra-
tion of Ca in serum. This result may be connected with the
role of Ca in the regulation of abdominal fat mass in obese
people [10].
Conclusions
The present findings demonstrate strong evidence for the
effect of GTE on the mineral status of obese people. Our
results suggest that GT improves the status of Zn and Mg in
such individuals. However, supplementation with GT can
deepen the deficit of Fe which is observed in obesity. More-
over, this study confirms the beneficial influence of GTE
supplementation on body mass, lipid profile, glucose, and
TAS in obese patients. As the subjects represented in the
Table 4 Within-group minerals concentration in serum at baseline and after 3 months of treatment










Fe (μmol/l) 17.91±2.20 17.28±3.16 NS 16.02±3.19* 16.91±2.97 NS
Zn (μmol/l) 12.09±2.12 12.45±3.11 NS 14.08±3.16* 13.01±2.98 <0.05
Cu (μmol/l) 13.97±3.12 14.30±2.13 NS 13.82±2.98 14.45±3.17 NS
Ca (mmol/l) 2.72±0.59 2.75±0.63 NS 2.92±0.92 2.98±0.69 NS
Mg (mmol/l) 0.97±0.52 1.05±0.76 NS 1.07±0.68* 1.09±0.43 NS
Data are mean ± SD; the arithmetic mean; SD standard deviation, n number of subjects; *p<0.05 from baseline to the end of treatment with paired t
test







coefficient; p, level of
significance
Minerals Parameters r; p
Baseline
Ca BMI 0.33; 0.042
Cu TG −0.34; 0.038
After treatment
Fe BMI 0.37; 0.023
Mg glucose −0.48; 0.002
Mg HDL 0.32; 0.023
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studied group are overrepresented in the modern population,
the potential advantages of GTE should be carefully evalu-
ated. Further studies on a larger scale and with a longer time
of observation are needed to support our data.
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